Filing Details

Accession Number:
0001628280-23-006991
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 16:21:24
Reporting Period:
2023-03-07
Accepted Time:
2023-03-08 16:21:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1766524 L. Sheldon Koenig C/O Esperion Therapeutics, Inc.
3891 Ranchero Drive, Suite 150
Ann Arbor MI 48108
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-03-07 5,441 $5.06 194,815 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units.
  2. Consists of 194,815 shares of common stock held, including 1,999 shares recently acquired in Esperion's Employee Stock Purchase Plan.